Coherus BioSciences Inc. (CHRS)
NASDAQ: CHRS
· Real-Time Price · USD
1.05
0.03 (2.94%)
At close: Aug 15, 2025, 1:09 PM
2.94% (1D)
| Bid | 0.74 |
| Market Cap | 121.59M |
| Revenue (ttm) | 197.5M |
| Net Income (ttm) | -130.94M |
| EPS (ttm) | 0.53 |
| PE Ratio (ttm) | 1.97 |
| Forward PE | -1.03 |
| Analyst | Buy |
| Ask | 1.1 |
| Volume | 814,763 |
| Avg. Volume (20D) | 1,306,877 |
| Open | 1.03 |
| Previous Close | 1.02 |
| Day's Range | 1.02 - 1.06 |
| 52-Week Range | 0.66 - 2.43 |
| Beta | 0.90 |
About CHRS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CHRS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CHRS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Coherus BioSciences has released their quartely earnings
on Aug 7, 2025:
Next Earnings Release
Coherus BioSciences Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-19.11%
Coherus BioSciences shares are trading lower. The ...
Unlock content with
Pro Subscription
4 months ago
+16.59%
Coherus BioSciences shares are trading higher after the company announced it completed UDENYCA franchise divestiture.
